Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_210_библиотеки_им_акад_М_И_Перельмана
.pdf
341
308. Sadik, R. The relationship between symptoms, body mass index,
gastrointestinal transit and stool frequency in patients with irritable bowel syndrome / R.
Sadik, E. Björnsson, M. Simrén // European Journal of Gastroenterology & Hepatology.
– 2010. – Vol. 22, N 1. – P.102–108.
309. Sartor, R.B. Roles for Intestinal Bacteria, Viruses, and Fungi in
Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches / R.B.
Sartor, G.D. Wu // Gastroenterology. – 2017. – Vol. 152, N 2. – P.327–339.e4.
310. Schlottmann, F. Obesity and esophageal cancer: GERD, Barrett´s
esophagus, and molecular carcinogenic pathways / F. Schlottmann, N.H. Dreifuss, M.G.
Patti // Expert Review of Gastroenterology & Hepatology. – 2020. – Vol. 14, N 6. –
P.425–433.
311. Schulze, M.B. Metabolic health in normal–weight and obese individuals /
M.B. Schulze // Diabetologia. – 2019. – Vol. 62, N 4. – P.558–566.
312. Selective increases of bifidobacteria in gut microflora improve high–fat–
diet–induced diabetes in mice through a mechanism associated with endotoxaemia / P.
D. Cani, A.M. Neyrinck, F. Fava [et al.] // Diabetologia. – 2007. – Vol. 50, N 11. –
P.2374–2383.
313. Sender, R. Revised Estimates for the Number of Human and Bacteria Cells
in the Body / R. Sender, S. Fuchs, R. Milo // PLoS biology. – 2016. – Vol. 14, N 8. –
P.e1002533.
314. Serotonin enhances the impact of health information on food choice / I.
Vlaev, M.J. Crockett, L. Clark [et al.] // Cognitive, Affective & Behavioral
Neuroscience. – 2017. – Vol. 17, N 3. – P.542–553.
315. Serotonin transporter binding and acquired obesity –– an imaging study of
monozygotic twin pairs / A.K. Koskela, S. Kaurijoki, K.H. Pietiläinen [et al.] //
Physiology & Behavior. – 2008. – Vol. 93,N 4–5. – P.724–732.
316. Sikander, A. Role of serotonin in gastrointestinal motility and irritable
bowel syndrome / A. Sikander, S.V. Rana, K.K. Prasad // Clinica Chimica Acta. – 2009.
– Vol. 403, N 1–2. – P.47–55.
https://t.me/med1917
342
317. Stenard, F. Laparoscopic sleeve gastrectomy and gastroesophageal reflux /
F. Stenard, A. Iannelli // World Journal of Gastroenterology. – 2015. – Vol. 21, N 36. –
P.10348–10357.
318. Stress and the Microbiota–Gut–Brain Axis in Visceral Pain: Relevance to
Irritable Bowel Syndrome / R.D. Moloney, A.C. Johnson, S.M. O’Mahony [et al.] //
CNS neuroscience & therapeutics. – 2016. – Vol. 22, N 2. – P.102–117.
319. Sub–clinical detection of gut microbial biomarkers of obesity and type 2
diabetes / M. Yassour, M.Y. Lim, H.S. Yun [et al.] // Genome Medicine. – 2016. – Vol.
8, N 1. – P.17.
320. Supplementation with Akkermansia muciniphila in overweight and obese
human volunteers: a proof–of–concept exploratory study / C. Depommier, A. Everard,
C. Druart [et al.] // Nature Medicine. – 2019. – Vol. 25, N 7. – P.1096–1103.
321. Systemic inflammation in the pathogenesis of irritable bowel syndrome
associated with obesity / Y.V. Bilooka, O.I. Fediv, H.Y. Stupnytska [et al.] // Journal of
Medicine and Life. – 2021. – Vol. 14, N 4. – P.531–535.
322. Taraszewska, A. Risk factors for gastroesophageal reflux disease
symptoms related to lifestyle and diet / A. Taraszewska // Roczniki Panstwowego
Zakladu Higieny. – 2021. – Vol. 72, N 1. – P.21–28.
323. The Chicago Classification of esophageal motility disorders, v3.0 / P.J.
Kahrilas, A.J. Bredenoord, M. Fox [et al.] // Neurogastroenterology and Motility. –
2015. – Vol. 27, N 2. – P.160–174.
324. The effect of breathing exercises on patients with GERD: a meta–analysis /
K. Qiu, J. Wang, B. Chen [et al.] // Annals of Palliative Medicine. – 2020. – Vol. 9, N 2.
– P.405–413.
325. The effect of long–term intake of cis unsaturated fats on the risk for
gallstone disease in men: a prospective cohort study / C.–J. Tsai, M.F. Leitzmann, W.C.
Willett, E.L. Giovannucci // Annals of Internal Medicine. – 2004. – Vol. 141, N 7. –
P.514–522.
https://t.me/med1917
343
326. The effect of rate of weight loss on long–term weight management: a
randomised controlled trial / K. Purcell, P. Sumithran, L.A. Prendergast [et al.] // The
Lancet. Diabetes & Endocrinology. – 2014. – Vol. 2, N 12. – P.954–962.
327. The effectiveness and risks of bariatric surgery: an updated systematic
review and meta–analysis, 2003–2012 / S.–H. Chang, C.R.T. Stoll, J. Song [et al.] //
JAMA surgery. – 2014. – Vol. 149, N 3. – P.275–287.
328. The ghrelin signalling system is involved in the consumption of sweets / S.
Landgren, J.A. Simms, D.S. Thelle [et al.] // PloS One. – 2011. – Vol. 6, N 3. –
P.e18170.
329. The insulin sensitivity Mcauley index (MCAi) is associated with 40–year
cancer mortality in a cohort of men and women free of diabetes at baseline / Y.
Moshkovits, D. Rott, A. Chetrit, R. Dankner // PloS One. – 2022. – Vol. 17, N 8. –
P.e0272437.
330. The microbiota–gut–brain axis in obesity / C. Torres–Fuentes, H.
Schellekens, T.G. Dinan, J.F. Cryan // The Lancet. Gastroenterology & Hepatology. –
2017. – Vol. 2, N 10. – P.747–756.
331. The Montreal definition and classification of gastroesophageal reflux
disease: a global evidence–based consensus / N. Vakil, S.V. van Zanten, P. Kahrilas [et
al.] // The American Journal of Gastroenterology. – 2006. – Vol. 101, N 8. – P.1900–
1920.
332. The past, present, and future of basal insulins / J. Pettus, T. Santos
Cavaiola, W.V. Tamborlane, S. Edelman // Diabetes/Metabolism Research and
Reviews. – 2016. – Vol. 32, N 6. – P.478–496.
333. The relationship between obesity and the severity of non–alcoholic fatty
liver disease: systematic review and meta–analysis / F.–B. Lu, E.–D. Hu, L.–M. Xu [et
al.] // Expert Review of Gastroenterology & Hepatology. – 2018. – Vol. 12, N 5. –
P.491–502.
334. The Role of Probiotics and Prebiotics in the Prevention and Treatment of
Obesity / T. Cerdó, J.A. García–Santos, M.G Bermúdez, C. Campoy // Nutrients. –
2019. – Vol. 11, N 3. – P.E635.
https://t.me/med1917
344
335. The Role of Symptom Association Analysis in Gastroesophageal Reflux
Testing / A.N. Kamal, J.O. Clarke, J.M. Oors [et al.] // The American Journal of
Gastroenterology. – 2020. – Vol. 115, N 12. – P.1950–1959.
336. The Science of Obesity Management: An Endocrine Society Scientific
Statement / G.A. Bray, W.E. Heisel, A. Afshin [et al.] // Endocrine Reviews. – 2018. –
Vol. 39, N 2. – P.79–132.
337. The Spielberger State–Trait Anxiety Inventory (STAI): the state scale in
detecting mental disorders in geriatric patients / K. Kvaal, I. Ulstein, I.H. Nordhus, K.
Engedal // International Journal of Geriatric Psychiatry. – 2005. – Vol. 20, N 7. –
P.629–634.
338. Thursby, E. Introduction to the human gut microbiota / E. Thursby, N. Juge
// The Biochemical Journal. – 2017. – Vol. 474, N 11. – P.1823–1836.
339. Transient lower esophageal sphincter relaxation in morbid obesity / J.H.
Schneider, M. Küper, A. Königsrainer, B. Brücher // Obesity Surgery. – 2009. – Vol.
19, N 5. – P.595–600.
340. Transmission of atherosclerosis susceptibility with gut microbial
transplantation / J.C. Gregory, J.A. Buffa, E. Org [et al.] // The Journal of Biological
Chemistry. – 2015. – Vol. 290, N 9. – P.5647–5660.
341. Treatment of selective serotonin reuptake inhibitor–resistant depression in
adolescents: predictors and moderators of treatment response / J.R. Asarnow, G. Emslie,
G. Clarke [et al.] // Journal of the American Academy of Child and Adolescent
Psychiatry. – 2009. – Vol. 48, N 3. – P.330–339.
342. Twenty–four hour ambulatory simultaneous impedance and pH monitoring:
a multicenter report of normal values from 60 healthy volunteers / S. Shay, R. Tutuian,
D. Sifrim [et al.] // The American Journal of Gastroenterology. – 2004. – Vol. 99, N 6. –
P.1037–1043.
343. Unexpected Rapid Increase in the Burden of NAFLD in China From 2008
to 2018: A Systematic Review and Meta–Analysis / F. Zhou, J. Zhou, W. Wang [et al.]
// Hepatology. – 2019. – Vol. 70, N 4. – P.1119–1133.
https://t.me/med1917
345
344. Update on the epidemiology of gastro–oesophageal reflux disease: a
systematic review / H.B. El–Serag, S. Sweet, C.C. Winchester, J. Dent // Gut. – 2014. –
Vol. 63, N 6. – P.871–880.
345. Updating and validating the Charlson comorbidity index and score for risk
adjustment in hospital discharge abstracts using data from 6 countries / H. Quan, B. Li,
C.M. Couris [et al.] // American Journal of Epidemiology. – 2011. – Vol. 173, N 6. –
P.676–682.
346. Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones
during weight loss: a meta–analysis of randomized controlled trials / C. S. Stokes, L.L.
Gluud, M. Casper, F. Lammert // Clinical Gastroenterology and Hepatology. – 2014. –
Vol. 12, N 7. – P.1090–1100.
347. Valassi, E. Neuroendocrine control of food intake / E. Valassi, M. Scacchi,
F. Cavagnini // Nutrition, metabolism, and cardiovascular diseases. – 2008. – Vol. 18, N
2. – P.158–168.
348. Validating the SF–36 health survey questionnaire: new outcome measure
for primary care / J.E. Brazier, R. Harper, N.M. Jones [et al.] // BMJ (Clinical research
ed.). – 1992. – Vol. 305, N 6846. – P.160–164.
349. Veldhuyzen van Zanten, S. Diamond GERD diagnosis studies: clinical
feelings are good, but are measurements using a PPI test better? / S. Veldhuyzen van
Zanten // Clinical Gastroenterology and Hepatology. – 2012. – Vol. 10, N 12. – P.1367–
1368.
350. Visceral abdominal obesity is associated with an increased risk of irritable
bowel syndrome / C.G. Lee, J.K. Lee, Y.–S. Kang [et al.] // The American Journal of
Gastroenterology. – 2015. – Vol. 110, N 2. – P.310–319.
351. Visceral hypersensitivity is together with psychological distress and female
gender associated with severity of IBS–like symptoms in quiescent ulcerative colitis /
G. Mavroudis, H. Strid, B. Jonefjäll, M. Simrén // Neurogastroenterology and Motility.
– 2021. – Vol. 33, N 3. – P.e13998.
https://t.me/med1917
346
352. Wade, D.T. The biopsychosocial model of illness: a model whose time has
come / D.T. Wade, P.W. Halligan // Clinical Rehabilitation. – 2017. – Vol. 31, N 8. –
P.995–1004.
353. Wang, H.–X. Gut Microbiota–brain Axis / H.–X. Wang, Y.–P. Wang //
Chinese Medical Journal. – 2016. – Vol. 129, N 19. – P.2373–2380.
354. Wardle, J. Eating style: a validation study of the Dutch Eating Behaviour
Questionnaire in normal subjects and women with eating disorders / J. Wardle // Journal
of Psychosomatic Research. – 1987. – Vol. 31, N 2. – P.161–169.
355. Watkins, L.F. Characterization of the synergistic effect of insulin and
transferrin and the regulation of their receptors on a human colon carcinoma cell line /
L.F. Watkins, L.R. Lewis, A.E. Levine // International Journal of Cancer. – 1990. – Vol.
45, N 2. – P.372–375.
356. Weight change and health outcomes at 3 years after bariatric surgery
among individuals with severe obesity / A.P. Courcoulas, N.J. Christian, S.H. Belle [et
al.] // JAMA. – 2013. – Vol. 310, N 22. – P.2416–2425.
357. Weight loss and reduction in gastroesophageal reflux. A prospective
population–based cohort study: the HUNT study / E. Ness–Jensen, A. Lindam, J.
Lagergren, K. Hveem // The American Journal of Gastroenterology. – 2013. – Vol. 108,
N 3. – P.376–382.
358. Weight loss can lead to resolution of gastroesophageal reflux disease
symptoms: a prospective intervention trial / M. Singh, J. Lee, N. Gupta [et al.] //
Obesity (Silver Spring, Md.). – 2013. – Vol. 21, N 2. – P.284–290.
359. WHO Expert Consultation. Appropriate body–mass index for Asian
populations and its implications for policy and intervention strategies / WHO Expert
Consultation // Lancet. – 2004. – Vol. 363, N 9403. – P.157–163.
360. Wisén O. Gastrointestinal function in obesity: motility, secretion, and
absorption following a liquid test meal / O. Wisén, C. Johansson // Metabolism: Clinical
and Experimental. – 1992. – Vol. 41, N 4. – P.390–395.
https://t.me/med1917
347
361. World Gastroenterology Organisation Global Guidelines: GERD Global
Perspective on Gastroesophageal Reflux Disease / R. Hunt, D. Armstrong, P. Katelaris
[et al.] // Journal of Clinical Gastroenterology. – 2017. – Vol. 51, N 6. – P.467–478.
362. Worldwide Prevalence and Burden of Functional Gastrointestinal
Disorders, Results of Rome Foundation Global Study / A.D. Sperber, S.I. Bangdiwala,
D.A. Drossman [et al.] // Gastroenterology. – 2021. – Vol. 160, N 1. – P.99–114.e3.
363. Woting, A. The Intestinal Microbiota in Metabolic Disease / A. Woting, M.
Blaut // Nutrients. – 2016. – Vol. 8, N 4. – P.202.
364. Wu, W.–C. Small intestinal bacteria overgrowth decreases small intestinal
motility in the NASH rats / W.-C. Wu, W. Zhao, S. Li // World Journal of
Gastroenterology. – 2008. – Vol. 14, N 2. – P.313–317.
365. Wu, Y.-K. Impact of weight stigma on physiological and psychological
health outcomes for overweight and obese adults: A systematic review / Y.-K. Wu, D.C.
Berry // Journal of Advanced Nursing. – 2018. – Vol. 74, N 5. – P.1030–1042.
366. Xylo–oligosaccharide (XOS) in combination with inulin modulates both
the intestinal environment and immune status in healthy subjects, while XOS alone only
shows prebiotic properties / J.-M. Lecerf, F. Dépeint, E. Clerc [et al.] // The British
Journal of Nutrition. – 2012. – Vol. 108, N 10. – P.1847–1858.
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана